Orphan blood disease drugs to gain market

Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This...

February 7, 2013 | Thursday | Analysis
German, Korean firm join hands to discover cancer drugs

Singapore: Germany's translational drug discovery organization, Lead Discovery Center (LDC), has entered into a licence ...

June 4, 2015 | Thursday | News
BMS, Pfizer gets FDA nod to review Eliquis

Singapore: U.S. Food and Drug Administration (FDA) has accepted to review Supplemental New Drug Application (sNDA) for E...

July 12, 2013 | Friday | Regulatory
Eisai expands R&D in Belgium with office in Brussels

Singapore: Eisai EMEA (Europe, Middle East, Africa, Russia and Oceania), the R&D division of the Japan-based company...

September 16, 2013 | Monday | News
Genzyme's Cerdelga capsules approved in Japan

Genzyme, a Sanofi company, announced that the Ministry of Health, Labour and Welfare (MHLW) has granted marketing approv...

April 1, 2015 | Wednesday | News
GE to open technology and training centre in Turkey

Singapore: GE Healthcare Life Sciences plans to open a technology and training laboratory in Turkey by mid-2015 targetti...

November 17, 2014 | Monday | News
Takeda terminates prostrate cancer drug trial

Singapore: Takeda Pharmaceutical has terminated the development program for orteronel (TAK-700) for prostate cancer foll...

June 24, 2014 | Tuesday | News
Panacea JV to yield generics revenue of $25 bn

New Delhi: Panacea Biotec entered into a strategic alliance for R&D and commercialization of drug delivery-based, ge...

September 12, 2012 | Wednesday | News
Fosun Pharma listed in CCTV Financial 50 Index Sample Stock

Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Sh...

August 14, 2013 | Wednesday | Company results
Military univ, Shanghai Pharma form alliance

Singapore: Shanghai Pharmaceuticals has entered into a strategic framework cooperation agreement with Secondary Military...

August 1, 2013 | Thursday | News
Singapore, Korea scientists find clue to tumour suppression mechanism

Singapore: RUNX3, a gene that is intensively studied for its function as a tumour suppressor, is likely to be a key and ...

November 12, 2013 | Tuesday | News
Ranbaxy redesigns strategy to meet regulations

The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the fi...

June 12, 2012 | Tuesday | Analysis
Patrys gets nod to continue myeloma trial

Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...

April 24, 2013 | Wednesday | News
TB Alliance starts clinical trial of drug resistant TB

Singapore: TB Alliance has started a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (X...

May 14, 2015 | Thursday | News
Ignyta acquires Teva's upcoming oncology program at $41.6 mn

Singapore: US based oncology biotechnology company, Ignyta, has acquired four targeted oncology development programs fro...

April 24, 2016 | Sunday | News
US firm files antibody patent in Japan, Korea

Singapore: MMRGlobal received confirmation of the filings of a divisional application for its antibody technology in Jap...

August 27, 2013 | Tuesday | News
Sphaera Pharma, DDRC, Wellcome Trust collaborate to foster TB research

Singapore: In a bid to further foster new drug research for drug resistant tuberculosis (TB), Wellcome Trust has collabo...

August 10, 2015 | Monday | News
J&J to open innovation centers in US, UK and China

Singapore: Johnson & Johnson plans to establish four regional innovation centers in major life sciences communities ...

September 19, 2012 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls